2012-09-11 09:02:02 - Natera is the most promising new entrant in the rapidly evolving NIPD market that is expected to capture a significant market share amongst its other competitors by 2016, says RNCOS.
According to a new research report by RNCOS entitled, “US Non-Invasive Prenatal Diagnostics - Market Insight”, Natera is amongst the most promising new entrants in the NIPD market and is expected to capture a significant market share amongst its other competitors by 2016. The Company is currently validating its NIPD test and its clinical studies are expected to be completed by December 2012. It is expected to launch its NIPD test in the early months of 2013, thereby adding a newer innovation to the existing portfolio of non-invasive tests and also creating an immediate threat to existing players, such as Verinata and Ariosa Diagnostics.
The NIPD sector evolved on account of the need for safer detection of chromosomal abnormalities. In the
US especially, the NIPD sector is expected to evolve particularly due to the limitations posed by the invasive diagnostic technologies, such as CVS and amniocentesis and a high demand. With only a handful of market players, the NIPD market currently is represented by companies, such as Sequenom, Verinata and Ariosa diagnostics and growth in the sector is expected to be in double digits. Further in the latest report by RNCOS, clinical trials and research in the field is also being carried on extensively with an expectation that the market will exhibit unprecedented growth in the future.
The report, spread in over 55 pages provides an in-depth research and rational analysis of the current status and expected position of the US NIPD Market. It facilitates the future forecasts on overall US NIPD Market size by 2016 and takes into account pessimistic and optimistic scenarios that could prevail in the market. Moreover, the report projects the potential market to be tapped by currently active market players. It also analyzes the opportunity assessment for companies in the US NIPD Market in terms of leading technologies. In addition it elaborates on the ongoing clinical trials and the various restraints faced by the sector. To provide a holistic view, it also provides a competitive assessment of the major players describing their key business and comparing their strengths and weaknesses.
For FREE SAMPLE of this report visit: www.rncos.com/Report/IM450.htm
Some of our Related Reports are:
- US Cardiac Device Market Analysis ( www.rncos.com/Report/IM441.htm
- US Clinical Laboratory Testing Market Assessment( www.rncos.com/Report/IM442.htm
- Global Genetic Testing Market Forecast to 2015 ( www.rncos.com/Report/IM445.htm
- Indian Diagnostic Services Market Outlook 2015 ( www.rncos.com/Report/IM418.htm
- US Nutraceuticals Market Analysis ( www.rncos.com/Report/IM350.htm
Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.